[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,670,438
  • Shares Outstanding, K 419,228
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,435 M
  • EBITDA $ 3,922 M
  • 60-Month Beta 0.75
  • Price/Sales 3.43
  • Price/Cash Flow 10.24
  • Price/Book 10.09

Options Overview Details

View History
  • Implied Volatility 50.04% (-0.69%)
  • Historical Volatility 28.52%
  • IV Percentile 96%
  • IV Rank 92.58%
  • IV High 52.24% on 07/22/26
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 22) 6.89 (9.06%)
  • Put/Call Vol Ratio 0.42
  • Today's Volume 7,387
  • Volume Avg (30-Day) 4,326
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 142,843
  • Open Int (30-Day) 147,938
  • Expected Range 69.15 to 82.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.84
  • Number of Estimates 8
  • High Estimate $1.89
  • Low Estimate $1.77
  • Prior Year $1.76
  • Growth Rate Est. (year over year) +4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.11 +5.44%
on 07/01/26
79.43 -4.28%
on 07/28/26
+4.17 (+5.80%)
since 06/30/26
3-Month
71.47 +6.38%
on 06/30/26
116.25 -34.60%
on 05/01/26
-38.94 (-33.87%)
since 04/30/26
52-Week
71.47 +6.38%
on 06/30/26
160.48 -52.62%
on 08/20/25
-72.78 (-48.91%)
since 07/30/25

Most Recent Stories

More News
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP  announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

ZTS : 76.03 (-2.44%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

NEW YORK , July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS).   Such investors are...

ZTS : 76.03 (-2.44%)
3 Healthcare Stocks with Competitive Advantages

3 Healthcare Stocks with Competitive Advantages

VRTX : 481.70 (-0.34%)
ZTS : 76.03 (-2.44%)
ALHC : 18.61 (+1.75%)
Deadline Soon: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming July 27, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on...

ZTS : 76.03 (-2.44%)
Zoetis Launches Portela® (relfovetmab) in Canada and the European Union

First long-acting anti-NGF monoclonal antibody therapy for cats offers three months of osteoarthritis pain relief with a single injection

ZTS : 76.03 (-2.44%)
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ZTS : 76.03 (-2.44%)
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

NEW YORK , July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

ZTS : 76.03 (-2.44%)
ZTS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ZTS Investors with Losses to Contact the Firm

Did you buy ZTS securities   between January 14, 2025, and May 6, 2026?

ZTS : 76.03 (-2.44%)
ZTS Deadline: ZTS Investors with Loses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK , July 20, 2026 /PRNewswire/ --

ZTS : 76.03 (-2.44%)
ZTS Deadline: Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14,...

ZTS : 76.03 (-2.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 79.31
2nd Resistance Point 78.34
1st Resistance Point 77.19
Last Price 76.03
1st Support Level 75.07
2nd Support Level 74.10
3rd Support Level 72.95

See More

52-Week High 160.48
Fibonacci 61.8% 126.48
Fibonacci 50% 115.97
Fibonacci 38.2% 105.47
Last Price 76.03
52-Week Low 71.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.